Publications
Article · PubMed · January 1, 2018
Successful Use of a Reduced Dose Regimen of Rituximab in a Case of Rheumatoid Arthritis with Raynaud's Syndrome.
Raifa Ivanova, М.В. Горемыкина, Natalya Glushkova, Sandro Vento
Rheumatoid Arthritis Research and TherapiesSystemic Sclerosis and Related DiseasesAutoimmune and Inflammatory Disorders Researchrituximabrheumatoid arthritisRaynaud's phenomenon
More by Natalya Glushkova
- Unmet Needs and Caregiving Burden Among Informal Caregivers of Older Adults: A Qualitative StudyNursing Reports · 2026
- An approach to assess the impact of measures mitigating burden associated with COVID-19 in Central Asia (Kazakhstan, Kyrgyzstan, Mongolia)Scientific Reports · 2026
- Understanding Cardiovascular Mortality and Disability in Central Asia: A GBD-Based Analysis and Forecast to 2050Epidemiology and Health Data Insights · 2026 · Citations: 1
- The Potential Role of Taurine in Cancer Therapy: Mechanisms of Action and Future DirectionsCurrent Medicinal Chemistry · 2026